Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Heparan Sulfate

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Senté Partners For Growth And Innovation In Regenerative Skincare
    Senté Partners For Growth And Innovation In Regenerative Skincare

    16 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sente-announces-strategic-partnership-and-equity-financing-to-accelerate-growth-and-innovation-in-regenerative-skincare-302738355.html

    PR NEWSWIRE
    16 Apr 2026
    Share Share
    Worldsymposium Showcases Tralensidase Alfa For Sanfilippo
    Worldsymposium Showcases Tralensidase Alfa For Sanfilippo

    05 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260205292673/en/Long-Term-Data-Presented-at-the-22nd-Annual-WORLDSymposium-Highlights-Tralesinidase-Alfa-Enzyme-Replacement-Therapys-Potential-as-the-First-Disease-Modifying-Treatment-Option-for-Sanfilippo-Syndrome-Type-B-MPS-IIIB

    BUSINESSWIRE
    05 Feb 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.